Nicollet Investment Management’s Align Technology ALGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
6,200
+158
+3% +$27.4K 0.32% 56
2026
Q1
$1.04M Sell
6,042
-250
-4% -$43.8K 0.35% 54
2025
Q4
$982K Buy
+6,292
New +$902K 0.31% 55
2020
Q1
Sell
-7,098
Closed -$1.98M 56
2019
Q4
$1.98M Buy
7,098
+33
+0.5% +$8.23K 0.93% 33
2019
Q3
$1.28M Buy
7,065
+15
+0.2% +$3.12K 0.81% 39
2019
Q2
$1.93M Sell
7,050
-45
-0.6% -$13.6K 1.21% 31
2019
Q1
$2.02M Buy
7,095
+35
+0.5% +$8.35K 1.33% 29
2018
Q4
$1.48M Sell
7,060
-70
-1% -$17.7K 1.17% 30
2018
Q3
$2.79M Buy
7,130
+170
+2% +$62.7K 1.82% 17
2018
Q2
$2.38M Buy
6,960
+130
+2% +$38.8K 1.72% 19
2018
Q1
$1.72M Buy
6,830
+15
+0.2% +$3.85K 1.33% 27
2017
Q4
$1.51M Buy
+6,815
New +$1.55M 1.24% 31

Other funds holding ALGN

Nicollet Investment Management's ALGN Position: Q2 2026 in Review

Nicollet Investment Management increased its Align Technology (ALGN) stake by 2.6% in Q2 2026, buying an estimated $27.4K and bringing the position to 6,200 shares worth $1.05M. The position accounts for 0.32% of the portfolio, ranked #56.

Nicollet Investment Management first reported a position in ALGN in Q4 2017 and has held it in 12 quarters since. The position peaked at $2.79M in Q3 2018. 669 funds tracked by Wall St. Rank hold ALGN as of Q2 2026.

  • Nicollet Investment Management held 6,200 shares of Align Technology worth $1.05M as of Q2 2026.
  • Nicollet Investment Management bought 158 Align Technology shares in Q2 2026, an estimated $27.4K.
  • Align Technology made up 0.32% of Nicollet Investment Management's portfolio in Q2 2026, its #56 holding.
  • Nicollet Investment Management first reported a position in Align Technology in Q4 2017 and has held it in 12 quarters since.
  • Nicollet Investment Management's Align Technology position peaked at $2.79M in Q3 2018.
  • 669 funds tracked by Wall St. Rank held Align Technology as of Q2 2026.

Based on Nicollet Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.